Rise was always going to happen. Covid is sexy. It’s a question of whether we can keep up momentum with progression of our own product.
I suspect we will get less than satisfactory clinical results because of sample contamination, but enough to progress to market. Then we have to find someone willing to buy from us on a competitive field.
We need better test results to stand out from the crowd - or success with saliva. Either of those two gives us a much better shot.
No idea whether SP momentum continues tomorrow or opportunists dump. Here’s hoping for the former.
-
- There are more pages in this discussion • 4,852 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
1.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $37.87M | |||
| Open | High | Low | Value | Volume |
| 1.5¢ | 1.5¢ | 1.4¢ | $34.97K | 2.366M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 1034040 | 1.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.5¢ | 4088579 | 10 |
View Market Depth
| Last trade - 16.10pm 26/06/2025 (20 minute delay) ? |
| ADO (ASX) Chart |